本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc.

1.89
-0.1000-5.03%
盘后1.900.0100+0.53%18:29 EDT
成交量:43.76万
成交额:82.45万
市值:5,588.71万
市盈率:-0.86
高:2.01
开:2.00
低:1.81
收:1.99
数据加载中...
2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/11

重要事件披露

8-K - Current report
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

8-K - Current report
2020/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/22

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses